|
Market Closed -
NYSE
16:02:57 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 30.42 USD | +1.91% |
|
+3.33% | +22.17% |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-21 | Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market | RE |
| Market Cap | 173B 155B 143B 130B 243B 16,424B 247B 1,720B 678B 8,605B 651B 637B 27,259B | P/E 2026 * |
18.8x | P/E 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 222B 198B 182B 166B 311B 20,982B 316B 2,197B 866B 10,993B 831B 814B 34,824B | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 3.59x |
| Free-Float |
59.05% | Yield 2026 * |
5.66% | Yield 2027 * | 5.7% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PFE | Delayed | |
CBOE
| PFE | Real-time | |
|
Xetra
| PFE | Delayed | |
|
Mexican S.E.
| PFE * | End-of-day quote | |
|
CBOE
| PFEs | Real-time | |
|
London S.E.
| PFZ | Delayed | |
|
Borsa Italiana
| 1PFE | End-of-day quote | |
|
Tradegate
| PFE | Real-time | |
|
Kazakhstan S.E.
| PFE_KZ | End-of-day quote | |
|
Bolsa De Valores De Colombia
| PFECO | End-of-day quote | |
|
Lima
| PFEUS | End-of-day quote | |
|
Wiener Boerse
| PFE | End-of-day quote | |
|
Boerse Muenchen
| PFE | Real-time | |
|
Bulgaria S.E.
| PFE | End-of-day quote | |
|
Swiss Exchange
| PFE | Delayed | |
|
Santiago S.E.
| PFECL | End-of-day quote | |
|
Deutsche Boerse AG
| PFE | Delayed | |
|
Santiago S.E.
| PFE | End-of-day quote | |
|
Börse Stuttgart
| PFE | Delayed | |
|
CBOE
| PFZ | Real-time | |
|
Swiss Exchange
| PFE | Delayed |
Last Transcript: Pfizer Inc.
| 1 day | +1.91% | ||
| 1 week | +3.33% | ||
| Current month | +6.66% | ||
| 1 month | +8.92% | ||
| 3 months | +22.56% | ||
| 6 months | +13.51% | ||
| Current year | +22.17% |
| 1 week | 29.25 |  | 30.44 |
| 1 month | 27.12 | | 30.44 |
| Current year | 23.62 | | 30.44 |
| 1 year | 23.62 | | 30.44 |
| 3 years | 20.92 | | 31.54 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Free | Chief Executive Officer | 20 | 0.0000% | ||
| 10/13/26 | Free | Chief Executive Officer | 71 | 0.0000% | ||
| 9/30/26 | Free | Chief Executive Officer | 21 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.91% | +3.33% | +23.06% | -0.75% | 173B | |
| +2.83% | +4.40% | +60.84% | +123.50% | 1,165B | |
| +3.81% | +5.66% | +38.70% | +74.91% | 645B | |
| +0.14% | +0.63% | +24.71% | +95.03% | 504B | |
| +0.03% | +3.27% | +39.79% | +64.06% | 380B | |
| -1.76% | +1.41% | +68.06% | +43.41% | 363B | |
| +1.58% | +2.37% | +22.91% | +51.98% | 297B | |
| +2.90% | +2.22% | +3.51% | +24.45% | 269B | |
| +2.04% | +3.05% | +51.12% | +60.42% | 237B | |
| +2.36% | -0.11% | +29.42% | +102.04% | 195B | |
| Average | +1.76% | +2.19% | +36.21% | +63.91% | 422.89B | |
| Weighted average by Cap. | +1.98% | +2.58% | +42.03% | +79.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.22B 55.54B 51.24B 46.55B 87.33B 5,894B 88.67B 617B 243B 3,088B 234B 229B 9,782B | 59.89B 53.46B 49.32B 44.81B 84.06B 5,673B 85.35B 594B 234B 2,972B 225B 220B 9,416B |
| Net income | 8.89B 7.93B 7.32B 6.65B 12.48B 842B 12.67B 88.18B 34.73B 441B 33.36B 32.65B 1,397B | 11.05B 9.86B 9.1B 8.27B 15.51B 1,047B 15.75B 110B 43.18B 548B 41.48B 40.59B 1,737B |
| Net Debt | 48.12B 42.95B 39.62B 36B 67.53B 4,558B 68.57B 477B 188B 2,388B 181B 177B 7,565B | 41.54B 37.08B 34.21B 31.08B 58.3B 3,935B 59.2B 412B 162B 2,061B 156B 153B 6,530B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$30.42 | +1.91% | 28,703,381 |
| 26-10-21 | US$29.85 | -0.86% | 22,217,675 |
| 26-10-20 | US$30.11 | +2.28% | 34,442,161 |
| 26-10-19 | US$29.44 | -0.47% | 20,816,617 |
| 26-10-16 | US$29.58 | +0.48% | 28,627,476 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
